Centre d’Expertise sur l’Altitude EXALT Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2016
NCT02778659
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Centre d’Expertise sur l’Altitude EXALT | EXAL